Boston Scientific Corporation
BSX
Kedudukan dalam Saham
#409
Penerangan syarikat ini hanya tersedia dalam bahasa Inggeris.
Boston Scientific Corporation (BSX) operates as a global leader in medical... Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the company provides a comprehensive portfolio of solutions addressing various gastrointestinal and pulmonary ailments, as well as urological and pelvic health concerns. This extends to advanced implantable devices for managing cardiac rhythm disorders, such as cardioverter-defibrillators, cardiac resynchronization therapy devices, and pacemakers, complemented by remote patient management systems. Furthermore, Boston Scientific offers sophisticated technologies for diagnosing and treating complex heart rate and rhythm irregularities. These encompass 3-D cardiac mapping and navigation tools, along with a suite of specialized catheters (including ablation, diagnostic, mapping, and intracardiac ultrasound types), delivery sheaths, and related accessories. Its offerings also extend to neurological conditions, providing spinal cord stimulator systems for chronic pain management, indirect decompression systems, and deep brain stimulation systems. In the realm of interventional cardiology, the company's innovations include drug-eluting coronary stent systems designed for treating coronary artery disease, products for percutaneous coronary interventions to combat atherosclerosis, and intravascular imaging catheters (such as ultrasound and fractional flow reserve devices) for assessing coronary arteries, heart chambers, and peripheral vessels. It also develops structural heart therapies. Beyond this, Boston Scientific supplies an array of stents, balloon catheters, wires, and atherectomy systems for the treatment of arterial diseases. For venous conditions, it provides thrombectomy and acoustic pulse thrombolysis systems, alongside wires and stents. Critically, the company also contributes to cancer treatment through peripheral embolization devices, radioactive microspheres, various ablation systems (including cryotherapy), and micro and drainage catheters. The organization was established in 1979 and maintains its corporate headquarters in Marlborough, Massachusetts.
Harga Saham
$41.88
Disegerakkan terakhir: 2026-10-30
Modal Pasaran
$60.69B
Perubahan (1 hari)
-1.89%
Perubahan (1 tahun)
-58.42%
Negara
US
Data saham: Financial Modeling PrepΒ·Dikemas kini Β·Bukan nasihat pelaburanΒ·Cara kami mengira
Perdagangan Boston Scientific Corporation (BSX)
Kategori
Healthcare
Pendapatan untuk Boston Scientific Corporation (BSX)
Pendapatan pada Sep 2026 TTM: $3.66B
Menurut laporan kewangan terkini Boston Scientific Corporation, pendapatan semasa syarikat ialah $3.66B. Pada tahun 2025, syarikat memperoleh pendapatan sebanyak $3.39B, peningkatan berbanding pendapatan pada tahun 2024 yang berjumlah $2.28B. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Boston Scientific Corporation dari 2000 hingga 2026
Pendapatan pada akhir setiap tahun
| Tahun | Pendapatan | Perubahan |
|---|---|---|
| 2026 (TTM) | $3.66B | 7.98% |
| 2025 | $3.39B | 48.33% |
| 2024 | $2.28B | 14.96% |
| 2023 | $1.99B | 73.97% |
| 2022 | $1.14B | 6.04% |
| 2021 | $1.08B | -1,462.03% |
| 2020 | $-79.00M | -111.50% |
| 2019 | $687.00M | -51.69% |
| 2018 | $1.42B | 52.41% |
| 2017 | $933.00M | 427.12% |
| 2016 | $177.00M | -127.23% |
| 2015 | $-650.00M | 27.70% |
| 2014 | $-509.00M | 128.25% |
| 2013 | $-223.00M | -94.57% |
| 2012 | $-4.11B | -739.72% |
| 2011 | $642.00M | -160.40% |
| 2010 | $-1.06B | -18.73% |
| 2009 | $-1.31B | -35.60% |
| 2008 | $-2.03B | 256.94% |
| 2007 | $-569.00M | -83.90% |
| 2006 | $-3.54B | -496.75% |
| 2005 | $891.00M | -40.36% |
| 2004 | $1.49B | 132.35% |
| 2003 | $643.00M | 17.12% |
| 2002 | $549.00M | 1,147.73% |
| 2001 | $44.00M | -91.65% |
| 2000 | $527.00M | 0.00% |
Pendapatan untuk syarikat atau pesaing serupa
| Syarikat | Pendapatan | Perbezaan Pendapatan | Negara |
|---|---|---|---|
| $6.56B | 79.53% |
US
|
|
| $6.60B | 80.66% |
IE
|
|
| $5.12B | 39.97% |
US
|
|
| $3.23B | -11.70% |
DE
|
|
| $1.42B | -61.21% |
US
|
Soalan tentang keuntungan bersih Boston Scientific Corporation
Berapakah keuntungan bersih Boston Scientific Corporation?
Setakat Sep 2026, keuntungan bersih Boston Scientific Corporation bagi tempoh 12 bulan yang lalu ialah $3.66B.
Berapakah keuntungan bersih Boston Scientific Corporation pada tahun 2025?
Pada tahun 2025, keuntungan bersih Boston Scientific Corporation ialah $3.39B, meningkat 48.33% berbanding tahun 2024 ($2.28B).
Bagaimanakah keuntungan bersih Boston Scientific Corporation berubah sejak tahun 2020?
Dari tahun 2020 hingga 2025, keuntungan bersih Boston Scientific Corporation paling tinggi pada tahun 2025 ($3.39B) dan paling rendah pada tahun 2020 ($-79.00M).
Bagaimanakah keuntungan bersih Boston Scientific Corporation berbanding syarikat yang serupa?
Dengan nilai $3.66B, keuntungan bersih Boston Scientific Corporation lebih tinggi berbanding 2 daripada 5 syarikat serupa yang disenaraikan di atas. Yang tertinggi dalam kalangan syarikat tersebut ialah Medtronic plc, dengan $6.60B.